Terms: = Lymphoma AND SH2B3, LNK, 10019, ENSG00000111252, Q9UQQ2
31 results:
1. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
2. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
3. Immune dysregulation associated with co-occurring germline CBL and sh2b3 variants.
Baccelli F; Leardini D; Muratore E; Messelodi D; Bertuccio SN; Chiriaco M; Cancrini C; Conti F; Castagnetti F; Pedace L; Pession A; Yoshimi A; Niemeyer C; Tartaglia M; Locatelli F; Masetti R
Hum Genomics; 2022 Sep; 16(1):40. PubMed ID: 36123612
[TBL] [Abstract] [Full Text] [Related]
4. Somatic homozygous loss of sh2b3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
[TBL] [Abstract] [Full Text] [Related]
5. Mutant
Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
[TBL] [Abstract] [Full Text] [Related]
6. Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.
Thomas KR; Allenspach EJ; Camp ND; Wray-Dutra MN; Khim S; Zielinska-Kwiatkowska A; Timms AE; Loftus JP; Liggitt HD; Georgopoulos K; Tasian SK; James RG; Rawlings DJ
Leukemia; 2022 Jan; 36(1):42-57. PubMed ID: 34193976
[TBL] [Abstract] [Full Text] [Related]
7. Deregulation of JAK2 signaling underlies primary cutaneous CD8
Bastidas Torres AN; Cats D; Out-Luiting JJ; Fanoni D; Mei H; Venegoni L; Willemze R; Vermeer MH; Berti E; Tensen CP
Haematologica; 2022 Mar; 107(3):702-714. PubMed ID: 33792220
[TBL] [Abstract] [Full Text] [Related]
8. [Research Progress on Pathogenic Genes of Ph-like Acute Lymphoblastic Leukemia--Review].
Li ZZ; Wang YJ; Feng JK; Tan JB; Zhao RB; Yang TH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):695-699. PubMed ID: 32319419
[TBL] [Abstract] [Full Text] [Related]
9. Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.
de Smith AJ; Lavoie G; Walsh KM; Aujla S; Evans E; Hansen HM; Smirnov I; Kang AY; Zenker M; Ceremsak JJ; Stieglitz E; Muskens IS; Roberts W; McKean-Cowdin R; Metayer C; Roux PP; Wiemels JL
Genes Chromosomes Cancer; 2019 Oct; 58(10):723-730. PubMed ID: 31102422
[TBL] [Abstract] [Full Text] [Related]
10. sh2b3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
[TBL] [Abstract] [Full Text] [Related]
11. CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia.
Jang W; Park J; Kwon A; Choi H; Kim J; Lee GD; Han E; Jekarl DW; Chae H; Han K; Yoon JH; Lee S; Chung NG; Cho B; Kim M; Kim Y
Exp Mol Med; 2019 Jan; 51(1):1-15. PubMed ID: 30635552
[TBL] [Abstract] [Full Text] [Related]
12. sh2b3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
[TBL] [Abstract] [Full Text] [Related]
13. [Expression of lnk Genes in Patients with Acute Leukemia and Its Clinical Significance].
Luo X; Tan M; Wu LS; Tian RM; Rong Y; Su Q; Zhu P; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):317-323. PubMed ID: 29665892
[TBL] [Abstract] [Full Text] [Related]
14. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract] [Full Text] [Related]
15. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
Reshmi SC; Harvey RC; Roberts KG; Stonerock E; Smith A; Jenkins H; Chen IM; Valentine M; Liu Y; Li Y; Shao Y; Easton J; Payne-Turner D; Gu Z; Tran TH; Nguyen JV; Devidas M; Dai Y; Heerema NA; Carroll AJ; Raetz EA; Borowitz MJ; Wood BL; Angiolillo AL; Burke MJ; Salzer WL; Zweidler-McKay PA; Rabin KR; Carroll WL; Zhang J; Loh ML; Mullighan CG; Willman CL; Gastier-Foster JM; Hunger SP
Blood; 2017 Jun; 129(25):3352-3361. PubMed ID: 28408464
[TBL] [Abstract] [Full Text] [Related]
16. [lnk Gene Single Nucleotide Polymorphisms and Acute Leukemia Susceptibility].
Wu LS; Han CS; Tan M; Zhu P; Bu FD; Zhang Y; Chen Y; Wu XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1305-1311. PubMed ID: 27784347
[TBL] [Abstract] [Full Text] [Related]
17. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
Roberti A; Dobay MP; Bisig B; Vallois D; Boéchat C; Lanitis E; Bouchindhomme B; Parrens MC; Bossard C; Quintanilla-Martinez L; Missiaglia E; Gaulard P; de Leval L
Nat Commun; 2016 Sep; 7():12602. PubMed ID: 27600764
[TBL] [Abstract] [Full Text] [Related]
18. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract] [Full Text] [Related]
19. Co-existence of IL7R high and sh2b3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.
Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C
Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554
[TBL] [Abstract] [Full Text] [Related]
20. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
[TBL] [Abstract] [Full Text] [Related]
[Next]
